322 related articles for article (PubMed ID: 27844211)
1. Morbid obesity and outcome of ectopic pregnancy following capped single-dose regimen methotrexate.
Hoyos LR; Malik M; Najjar M; Rodriguez-Kovacs J; Abdallah M; Vilchez G; Awonuga AO
Arch Gynecol Obstet; 2017 Feb; 295(2):375-381. PubMed ID: 27844211
[TBL] [Abstract][Full Text] [Related]
2. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
3. Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.
Dai Y; Zhang G; Zhu L; Lang J; Liu Z
J Minim Invasive Gynecol; 2017; 24(7):1195-1199. PubMed ID: 28800968
[TBL] [Abstract][Full Text] [Related]
4. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
5. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
6. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
Hutchinson AP; Pereira N; Chung ER; Shah NJ; Zeku M; Chung PH; Rosenwaks Z
Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG.
Levin G; Dior U; Shushan A; Gilad R; Benshushan A; Rottenstreich A
Reprod Biomed Online; 2019 Jul; 39(1):149-154. PubMed ID: 31029556
[TBL] [Abstract][Full Text] [Related]
9. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
Tug N; Sargin MA; Yassa M
Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453
[TBL] [Abstract][Full Text] [Related]
10. The effect of parental 5,10-methylenetetrahydrofolate reductase 677C/T and 1298A/C gene polymorphisms on response to single-dose methotrexate in tubal ectopic pregnancy.
Kutuk MS; Subasioglu A; Uludag S; Tascioglu N; Ozgun MT; Dundar M
J Matern Fetal Neonatal Med; 2017 May; 30(10):1232-1237. PubMed ID: 27379466
[TBL] [Abstract][Full Text] [Related]
11. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
[TBL] [Abstract][Full Text] [Related]
12. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
13. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate.
da Costa Soares R; Elito J; Camano L
Arch Gynecol Obstet; 2008 Oct; 278(4):319-24. PubMed ID: 18274766
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the parameters in predicting single-dose methotrexate therapy success for ectopic pregnancy.
Deniz S; Ali B; Canan U; Yılmaz AH; Olcay I; Burcu D; Fatma GK
J Obstet Gynaecol Res; 2024 May; 50(5):856-863. PubMed ID: 38476034
[TBL] [Abstract][Full Text] [Related]
15. Rate of hourly change in serum beta-human chorionic gonadotropin levels in ectopic pregnancy can predict the success of treatment with single-dose methotrexate: A retrospective observational study.
Lavie G; Kais M; Tendler R; Marwan O; Bornstein J; Sharon A
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():39-43. PubMed ID: 34418695
[TBL] [Abstract][Full Text] [Related]
16. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
18. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
Yıldız A; Bilge O
Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
[TBL] [Abstract][Full Text] [Related]
19. Trichosanthin, a Chinese medicine for the medical treatment of ectopic pregnancy with high levels of β-hCG.
Xiang DJ; Chen LM; Gu JS; Stone P; Chen Q
Reprod Sci; 2012 May; 19(5):534-8. PubMed ID: 22267541
[TBL] [Abstract][Full Text] [Related]
20. Management of ectopic pregnancies with poor prognosis through ultrasound guided intrasacular injection of methotrexate, series of 14 cases.
Andrés MP; Campillos JM; Lapresta M; Lahoz I; Crespo R; Tobajas J
Arch Gynecol Obstet; 2012 Feb; 285(2):529-33. PubMed ID: 21837423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]